Clayton, Dubilier & Rice, LLC
Clayton, Dubilier & Rice, LLC reported 2 US-listed holdings worth $895.0 million in its 13F for the quarter ended 30 June 2026, filed 29 July 2026. Its largest: Resideo Technologies, Inc. (52.1%) and Agilon Health Inc. Com New (47.9%). Against the quarter before, it opened 0 positions, added to 1, trimmed 0 and sold out of 0.
The 2 largest of its 2 positions, each sized by its share of the reported holdings, coloured by the change in shares against Q1 2026.
What the fund reported holding at each quarter's end; hover a bar for the number of positions
What its reported holdings returned
Held through each quarter, the holdings it reported returned -25.6% over the 7 quarters to 30 June 2026, against +30.2% for the S&P 500.
Not the fund's own return: each 13F's holdings are kept unchanged until the next one, so trades inside a quarter, dividends, cash and fees are left out. A rough guide to how its picks have done over time.
What it did on the quarter
Its positions against its 13F for the quarter to 31 March 2026; a change under 0.1% of a position counts as held
Added to 1
- Resideo Technologies, Inc. REZI+15,774 shares · +0%
What it holds
| Company | Shares | Value | Of its book | Change in shares |
|---|---|---|---|---|
| Resideo Technologies, Inc. REZI | 15.0M | $466.2 million | 52.10% | +15.8K |
| Agilon Health Inc. Com New AGL | 4.0M | $428.7 million | 47.90% | no change |